News
-
-
-
PRESS RELEASE
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan
SOPHiA GENETICS provides preliminary financial results for Q4 2025, forecasts 20-22% revenue growth in 2026, and announces executive transition plan with Ross Muken appointed as CEO -
-
-